Photostable Small-Molecule NIR-II Fluorescent Scaffolds that Cross the Blood-Brain Barrier for Noninvasive Brain Imaging.
Shichao WangHui ShiLushun WangAxel LoredoSergei M BachiloWilliam WuZeru TianYuda ChenR Bruce WeismanXuanjun ZhangZhen ChengHan XiaoPublished in: Journal of the American Chemical Society (2022)
The second near-infrared (NIR-II, 1000-1700 nm) fluorescent probes have significant advantages over visible or NIR-I (600-900 nm) imaging for both depth of penetration and level of resolution. Since the blood-brain barrier (BBB) prevents most molecules from entering the central nervous system, NIR-II dyes with large molecular frameworks have limited applications for brain imaging. In this work, we developed a series of boron difluoride (BF 2 ) formazanate NIR-II dyes, which had tunable photophysical properties, ultrahigh photostability, excellent biological stability, and strong brightness. Modulation of the aniline moiety of BF 2 formazanate dyes significantly enhances their abilities to cross the BBB for noninvasive brain imaging. Furthermore, the intact mouse brain imaging and dynamic dye diffusion across the BBB were monitored using these BF 2 formazanate dyes in the NIR-II region. In murine glioblastoma models, these dyes can differentiate tumors from normal brain tissues. We anticipate that this new type of small molecule will find potential applications in creating probes and drugs relevant to theranostic for brain pathologies.
Keyphrases
- fluorescence imaging
- photodynamic therapy
- small molecule
- high resolution
- fluorescent probe
- white matter
- resting state
- living cells
- drug release
- blood brain barrier
- functional connectivity
- quantum dots
- single molecule
- aqueous solution
- cerebral ischemia
- gene expression
- protein protein
- mouse model
- optical coherence tomography
- mass spectrometry
- risk assessment
- label free
- cerebrospinal fluid